BRPI0516134A - neurotoxinas de clostridium para uso na cicatrização de tecidos - Google Patents

neurotoxinas de clostridium para uso na cicatrização de tecidos

Info

Publication number
BRPI0516134A
BRPI0516134A BRPI0516134-7A BRPI0516134A BRPI0516134A BR PI0516134 A BRPI0516134 A BR PI0516134A BR PI0516134 A BRPI0516134 A BR PI0516134A BR PI0516134 A BRPI0516134 A BR PI0516134A
Authority
BR
Brazil
Prior art keywords
neurotoxins
clostridium
tissue
damaged
healing
Prior art date
Application number
BRPI0516134-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Harold Victor Taylor
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of BRPI0516134A publication Critical patent/BRPI0516134A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0516134-7A 2004-09-27 2005-09-27 neurotoxinas de clostridium para uso na cicatrização de tecidos BRPI0516134A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61339204P 2004-09-27 2004-09-27
PCT/GB2005/003728 WO2006035225A1 (en) 2004-09-27 2005-09-27 Clostridial neurotoxins for use in tissue healing

Publications (1)

Publication Number Publication Date
BRPI0516134A true BRPI0516134A (pt) 2008-08-26

Family

ID=35355850

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516134-7A BRPI0516134A (pt) 2004-09-27 2005-09-27 neurotoxinas de clostridium para uso na cicatrização de tecidos

Country Status (13)

Country Link
US (1) US20060067950A1 (ru)
EP (1) EP1799254A1 (ru)
KR (1) KR20070057862A (ru)
CN (1) CN101027083A (ru)
AU (1) AU2005288758A1 (ru)
BR (1) BRPI0516134A (ru)
CA (1) CA2580122A1 (ru)
EA (1) EA200700739A1 (ru)
IL (1) IL182153A0 (ru)
MX (1) MX2007003407A (ru)
NO (1) NO20072155L (ru)
WO (1) WO2006035225A1 (ru)
ZA (1) ZA200702484B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
AR061669A1 (es) 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
WO2015126527A1 (en) * 2014-02-18 2015-08-27 Kaufman-Janette Joely Botulinum neurotoxin for use in the prophylactic treatment of cutaneous wounds
US20200023044A1 (en) * 2017-03-22 2020-01-23 Bonti, Inc. Botulinum neurotoxins for treating traumatic injuries
CN110691579A (zh) 2017-03-22 2020-01-14 邦蒂公司 用于治疗的肉毒杆菌神经毒素
CN107469065B (zh) * 2017-07-19 2021-05-18 广州医科大学 类蛇毒三胜肽在制备用于治疗皮肤溃疡的药物中的应用
US20190183987A1 (en) * 2017-12-18 2019-06-20 Bonti, Inc. Neurotoxins for use in minimizing scarring

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE216589T1 (de) * 1996-11-27 2002-05-15 William J Binder Neurotoxine zur behandlung von hauterkrankungen bei säugetieren
EP1128844B1 (en) * 1998-10-27 2006-01-04 Mayo Foundation For Medical Education And Research Botulinum toxins for enhancing wound healing
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
US8048423B2 (en) * 2003-12-09 2011-11-01 Allergan, Inc. Botulinum toxin therapy for skin disorders

Also Published As

Publication number Publication date
WO2006035225A1 (en) 2006-04-06
IL182153A0 (en) 2007-07-24
CN101027083A (zh) 2007-08-29
MX2007003407A (es) 2007-05-23
KR20070057862A (ko) 2007-06-07
US20060067950A1 (en) 2006-03-30
EA200700739A1 (ru) 2007-10-26
NO20072155L (no) 2007-04-26
AU2005288758A1 (en) 2006-04-06
CA2580122A1 (en) 2006-04-06
EP1799254A1 (en) 2007-06-27
ZA200702484B (en) 2008-11-26

Similar Documents

Publication Publication Date Title
BRPI0516134A (pt) neurotoxinas de clostridium para uso na cicatrização de tecidos
ECSP077328A (es) Neurotoxinas clostridiales para uso en la cicatrización de tejidos
Paschos et al. Primary closure versus non-closure of dog bite wounds. A randomised controlled trial
Gómez-Cardero et al. Postoperative analgesia in TKA: ropivacaine continuous intraarticular infusion
Zhou et al. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
BRPI0513168A (pt) memantina como tratamento adjunto para antipsicóticos atìpicos em pacientes com esquizofrenia
ES2249490T3 (es) Articulos quirurgicos.
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
IL171607A (en) Use of botulinum toxin for the treatment of sinusitis-induced headaches
BR0316906A (pt) administração do capsaicinoides
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
BR0315319A (pt) Terapias e procedimentos dentais com toxina botulìnica
BRPI0415713A (pt) mio-inositol hexafosfato para uso tópico
Wang et al. Intra-articular injection of hyaluronic acid for the reduction in joint adhesion formation in a rabbit model of knee injury
WO2007056301A3 (en) Antibody therapy for treatment of diseases associated with gluten intolerance
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
Grunebaum et al. Lip and perioral trauma
BR0214196A (pt) Método e composição para reduzir a atividade de inibir o crescimento de uma célula cancerosa, para tratar de paciente com câncer
ATE458819T1 (de) Konjugat mit p21-protein zur krebsbehandlung
BR0107960A (pt) Tratamento de condições alérgicas e inflamatórias
Taylor et al. Efficacy of variable‐particle hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator‐blinded comparative trial
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
BRPI0418138A (pt) medicamento compreendendo ptx3, sozinho ou em combinação com tsg-6, para tratar doenças degenerativas de cartilagem e ósseas e tratar infertilidade feminina
Matthews-Brzozowska et al. Mesotherapy–a method of facial skin rejuvenation from an interdisciplinary perspective on improving facial aesthetics

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.